This knowledge of the individual reaction of individual cells is a key to more effective cancer therapies, the federal technology institute ETH Zurich said in a statement on Wednesday.
The new method, which is based on machine learning, was presented by researchers from ETH Zurich, the University of Zurich and the University Hospital Zurich in the scientific journal Nature Methods.
According to the paper, the predictions of the reactions of individual cells are made on the basis of cell samples. They ultimately indicate how well a patient’s cells respond to a drug.
“Instead of relying on average values of an entire cell population, our method can precisely describe and even predict how individual cells react to a disturbance, such as by an active substance,” study leader Gunnar Rätsch from ETH Zurich and the University Hospital Zurich explained. This makes more precise therapies and diagnoses possible.
However, comprehensive clinical studies are still necessary before the method can be used in clinical practice. So far, the researchers have proven that the method provides accurate predictions. In addition, according to the university, the researchers were able to show that the cancer cells also work with other disease-causing cells. For example, in the autoimmune disease lupus erythematosus.
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles. You can find them here.
If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.
External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
Popular Stories
More
Workplace Switzerland
What lies ahead for Switzerland: an economic outlook for 2025
Have you heard something about Swiss diplomacy that you’d like us to fact check?
Not all information circulating about Switzerland’s foreign relations is accurate or well understood. Tell us what you'd like us to fact check or clarify.
Credit Suisse Nazi ties ‘ran deeper than thought’: media report
This content was published on
Credit Suisse is alleged to have withheld details of its historic links with World War II-era Nazi clients, says the Wall Street Journal.
Swiss man faces life imprisonment after Australia drugs arrest
This content was published on
Swiss man, 21, accused of attempting to smuggle 25 kilograms of cocaine with a street value of CHF4.5 million into Australia.
Swiss insurer Helvetia says 500 jobs affected by cost-cutting
This content was published on
Some 500 jobs, including 200 to 250 in Switzerland, are affected by the new operational efficiency measures recently announced by insurer Helvetia.
This content was published on
Significantly fewer new cars were sold in Switzerland in 2024 than the previous year as demand for electric cars and plug-in hybrids declined.
Three Swiss brands among world’s 100 most valuable firms
This content was published on
Three Swiss firms made it into the 2024 top 100 most valuable companies in the world, despite Roche, Nestlé and Novartis falling down the rankings.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.